Загрузка...

Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Aromatase inhibitors (AIs) have been associated with cardiovascular disease in adjuvant randomized controlled trials (RCTs) comparing these drugs to tamoxifen. However, it is unclear whether this risk is real or due to cardioprotective effects of tamoxifen. To address this question, we c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Oncol
Главные авторы: Khosrow-Khavar, F., Filion, K. B., Al-Qurashi, S., Torabi, N., Bouganim, N., Suissa, S., Azoulay, L.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834146/
https://ncbi.nlm.nih.gov/pubmed/27998966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw673
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!